Life Sciences Tools and Services
Company Overview of Plant Bioscience Limited
Plant Bioscience Limited provides technology investment, intellectual property (IP) management, and licensing services for bioscience companies and investors in the United Kingdom and internationally. The company develops a range of technologies for licensing in plant science, microbiology, general biotechnology, health and medicine, nutritional, and food technology that are sourced from various research institutes and universities; and provides technology investment services for public sector researchers. It also provides patent consultation and management services that include IP identification and assessment, IP strategy definition and implementation, initial patent application drafting, ...
Norwich Research Park
Norwich, NR4 7UH
Founded in 1994
Key Executives for Plant Bioscience Limited
Compensation as of Fiscal Year 2017.
Plant Bioscience Limited Key Developments
Calyxt, Inc. Enters Technology Framework Collaboration with Plant Bioscience Limited
Mar 10 17
Calyxt Inc., has signed a technology framework agreement with Plant Bioscience Limited to expand Calyxt's intellectual property (IP) portfolio to include new product-based IP from leading academic institutions around the world. Under the new agreement, Plant Bioscience will offer newly developed technologies to Calyxt for evaluation and possible acquisition. The new collaboration brings Plant Bioscience's expertise and network as part of an overall strategy to expand Calyxt's existing trait portfolio and will expedite Calyxt's ability to grow its crop development pipeline.
Calyxt, Inc. Announces New Technology Framework Agreement with Plant Bioscience Limited to Expand IP Portfolio
Mar 9 17
Calyxt Inc. announced that it has signed a technology framework agreement with Plant Bioscience Limited to expand Calyxt's intellectual property portfolio to include new product-based IP from leading academic institutions around the world. Under the new agreement, PBL will offer newly developed technologies to Calyxt for evaluation and possible acquisition. Calyxt previously announced licensing agreements with PBL that boosted the trait development pipeline at the Company, including those for a resistance trait for powdery mildew - a devastating disease in wheat, as well as for rice and corn - developed through gene editing by the Institute of Genetics and Developmental Biology. This new collaboration brings PBL’s expertise and network as part of an overall strategy to expand Calyxt's existing trait portfolio and will expedite Calyxt's ability to grow its crop development pipeline. As a consumer- and product-focused company, Calyxt's ability to license traits that are developed by world-class academic institutions will ensure that Calyxt is ahead of the curve in developing the healthiest and most sustainable food products, with traits that consumers all over the world desire.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries